Find News

Filter articles

Applied Filters

Showing 91 to 100 of 642 results

LSPN Europe 2018: SPCs—important but ‘phenomenally complicated’, say lawyers


Supplementary protection certificates are hugely important to MSD’s business, according to Elena Böhles, assistant counsel at the pharmaceutical company, based in Hertfordshire, UK.

LSPN Europe 2018: Chinese filings impressive statement, says EPO director

China, EPO15-11-2018

Last year, for the first time in European Patent Office history, a Chinese company filed the most European patent applications, making an “impressive statement” on what companies in the country are doing, according to Peter Albrecht. 

LSPN Europe 2018: Technology advancing at ‘incredible pace’ in life sciences

EU, US15-11-2018

The speed of technological advancements in the life sciences industry is forcing patent lawyers to consider whether the norms they’re used to dealing with in the profession still apply.

Warner-Lambert v Actavis ‘disappointing’ for innovators: lawyers


The UK Supreme Court’s decision in Warner-Lambert v Actavis is disappointing for pharmaceutical innovators, and enforcing second medical use patents may now be more challenging, lawyers have told LSIPR.

UK Supreme Court issues Warner-Lambert v Actavis ruling


The UK Supreme Court today dismissed Warner-Lambert’s appeal in its pregabalin patent dispute with Actavis, while clarifying the role of plausibility in the sufficiency of patent applications. 

UK life sciences bodies submit concerns over ‘no deal’ Brexit

EU, UK12-11-2018

Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.

Hikma and Vectura collaborate to develop GSK generics

Jordan, UK12-11-2018

Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products. 

Roche, Boehringer and AbbVie have strong pot portfolios: report

International, US09-11-2018

The strongest cannabidiol patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week.

EPO revokes Bayer broccoli patent


The European Patent Office has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier. 

AbbVie and Momenta announce Humira patent licence agreement

EU, US08-11-2018

Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923.

Showing 91 to 100 of 642 results